文献速递血液净化与透析

儿童维持性透析中前稀释与后稀释血液透析滤过的随机交叉试验:对溶质清除和血压的影响

A randomised cross-over trial of pre- and post-filter haemodiafiltration modalities in children on maintenance dialysis - effects on solute removal and blood pressure.
PubMed 文献 · Kidney Int · 2026-09-16

该随机多中心交叉试验比较了前稀释与后稀释血液透析滤过(HDF)对24名维持性透析儿童溶质清除、炎症、营养指标和血压的影响。结果显示前稀释HDF对中大分子尿毒症毒素清除更优且炎症指标更低,但舒张压更高,可能与置换液量更大导致钠负荷增加有关。

要点

  • 前稀释HDF对中大分子溶质清除更优且炎症指标更低。
  • 前稀释HDF不损害小分子溶质清除或白蛋白水平。
  • 前稀释HDF可能与部分患者血压升高相关,需关注钠负荷。

核心结论

  • 前稀释HDF对中大分子尿毒症毒素清除更优且炎症指标更有利,不损害小分子溶质清除或白蛋白水平。
  • 前稀释HDF可能与部分患者血压升高相关,可能源于更高置换液量带来的钠负荷。

研究设计与样本

  • 随机多中心交叉试验,24名维持性透析儿童随机分为前稀释HDF后后稀释HDF或反之,各4周,洗脱期4周。
  • 21名患者完成研究,中位年龄15.1岁,15名(71%)为女孩。

主要发现

  • 前稀释HDF中位对流体积为36.2(IQR 32;40)L/m²体表面积/次,后稀释HDF为14.3(12.9;15.8)L/m²体表面积/次。
  • 前稀释HDF透析前α1-微球蛋白中位差异-17.0 ng/ml(95%CI -27.0;-3.5),β2-微球蛋白-5.19 mg/l(95%CI -9.34;-1.76),肌红蛋白-76.0 ng/ml(95%CI -100;-44.5),均显著更低。
  • 前稀释HDF中白介素-10、肿瘤坏死因子-α和高敏C反应蛋白显著更低。
  • 前稀释HDF对总硫酸吲哚酚和对甲酚硫酸盐的下降率显著更高。
  • 前稀释HDF舒张压显著更高,与更高置换体积和更高透析后血清钠浓度相关。

关键数值与推荐

  • 前稀释HDF对α1-微球蛋白、β2-微球蛋白、肌红蛋白的下降率显著高于后稀释HDF。
  • 小分子溶质下降率、Kt/V和血清白蛋白在两种模式间无有意义差异。

临床怎么用

  • 在儿童维持性透析中,可考虑前稀释HDF以增强中大分子毒素清除并改善炎症状态。
  • 采用前稀释HDF时需监测血压和血清钠,尤其对于置换液量较大的患者。

局限性

  • 样本量较小,完成研究仅21例。
  • 研究周期较短,各模式仅4周。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Children on post-filter hemodiafiltration (post-HDF) have reduced cardiovascular damage and improved growth compared to conventional hemodialysis. High convection volumes in post-HDF are associated with improved outcomes. Even higher convection volumes can be reached with pre-filter HDF (pre-HDF). However, data is limited. Here, we compare the effect of pre- vs post-HDF on solute removal, inflammation, nutrition markers and blood pressure in a randomized, multicenter cross-over trial. METHODS: After a four-week wash-out period in post-HDF, 24 children on maintenance dialysis were randomized either to four-weeks pre- then four-weeks post-HDF, or vice-versa, keeping all other dialysis related parameters constant. The primary outcome measure was reduction in α1-microglobulin, a large-middle molecular weight (MW) uremic retention solute. RESULTS: Twenty-one patients completed the study. The median age was 15.1 years, with 15(71%) girls. Median convection volumes were 36.2 (inter quartile range 32;40) vs 14.3 (12.9;15.8) l/m2 body surface area per session in pre-HDF and post-HDF respectively. Pre-dialysis α1- microglobulin [median difference -17.0 ng/ml (95% confidence interval (CI) -27.0;-3.5)], ß2-microglobulin [-5.19 mg/l (95%CI -9.34;-1.76)] and myoglobin [-76.0 ng/ml (95%CI-100;-44.5)] concentrations were significantly lower, and reduction ratios (RR) were significantly higher in pre-HDF compared with post-HDF. Interleukin-10, tumor necrosis factor-α and high sensitivity C-reactive protein were significantly lower in pre-HDF. Pre-HDF achieved significantly higher RRs of total indoxyl sulfate and p-cresyl sulfate. The RR for small MW solutes, Kt/V and serum albumin did not differ meaningfully between modalities. Diastolic blood pressure was significantly higher in pre-HDF, correlating with higher replacement volume and higher post-dialysis serum sodium concentration. CONCLUSIONS: Pre-HDF achieves superior removal of middle and larger-middle MW uraemic retention solutes and was associated with a more favorable inflammatory profile, without compromising small MW retention solute removal or albumin levels, compared to post-HDF. Pre-HDF may be associated with higher blood pressure in a sub-set of patients, potentially due to greater sodium load from higher replacement volumes. TRIAL REGISTRATION: Registered at ClinicalTrials.gov with study number NCT04210154.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Agbas A, Canpolat N, Ranchin B, et al. A randomised cross-over trial of pre- and post-filter haemodiafiltration modalities in children on maintenance dialysis - effects on solute removal and blood pressure. Kidney Int. 2026. PMID: 42749052. doi:10.1016/j.kint.2026.07.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。